Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin
189 In conclusion, TP53 germline mutations lead to a wide range of diseases by influencing various genes and signaling pathways

Wegovy (semaglutide) prescribing information, Food and Drug Administration (2024) Insulin resistance & prediabetes, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2025) Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): A randomised, double-blind, placebo-controlled, multicentre phase 3 trial, The Lancet Diabetes & Endocrinology (2024) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, Food and Drug Administration (2024) What is the list price for Wegovy and will it impact me?, NovoCare Details about the program, Centers for Disease Control and Prevention (2024) Medicare Diabetes Prevention Program, Centers for Medicare and Medicaid Services Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

MOLEonline: a web-based tool for analyzing channels, tunnels and pores (2018 update)
Scientific Discovery for CRC MRD - The need for bench to bedside clinical trials
If you notice any side effects while on this medicine, promptly notify your doctor